National Heart, Lung, and Blood Institute; Notice of Meeting, 9912 [2010-4492]
Download as PDF
9912
Federal Register / Vol. 75, No. 42 / Thursday, March 4, 2010 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160,
MSC 7842, Bethesda, MD 20892. (301) 435–
1727. schneidd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR08–22:
FIRCA and GRIP in Behavioral Social
Sciences.
Date: March 26, 2010.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott Chevy Chase,
5520 Wisconsin Avenue, Chevy Chase, MD
20815.
Contact Person: Dan D. Gerendasy, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7843, Bethesda, MD 20892. 301–408–
9164. gerendad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Fellowship:
Technology Development.
Date: April 1, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott Chevy Chase,
5520 Wisconsin Ave, Chevy Chase, MD
20815.
Contact Person: Alessandra M. Bini, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142,
MSC 7840, Bethesda, MD 20892. 301–435–
1024. binia@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
16:39 Mar 03, 2010
Jkt 220001
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and
Blood Program Project Review Committee.
Date: March 19, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey H. Hurst, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7208,
Bethesda, MD 20892–7924, 301–435–0303,
hurstj@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–4493 Filed 3–3–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Sickle
Cell Disease Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
[FR Doc. 2010–4494 Filed 3–3–10; 8:45 am]
VerDate Nov<24>2008
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: March 26, 2010.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: Discussion of Programs and
Issues.
Place: National Institutes of Health, 6701
Rockledge Drive, 10th Floor, Conference
Room 10091, Bethesda, MD 20892.
Contact Person: W. Keith Hoots, Director,
Division of Blood Diseases and Resources,
National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Suite 9030, Bethesda,
MD 20892, 301–435–0080,
hootswk@nhlbi.nih.gov.
Information is also available on the
Institute’s/Center’s home page: http:/
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–4492 Filed 3–3–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(6), Title 5 U.S.C., as
amended to discuss personnel matters,
the disclosure of which would
constitute a clearly unwarranted
invasion of privacy.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: March 22, 2010.
Open: 10 a.m. to 1:15 p.m.
Agenda: To review the FY11 Clinical
Center Budget.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Closed: 1:15 p.m. to 2 p.m.
Agenda: To review and evaluate personnel
matters.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Contact Person: Maureen E Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, (301) 496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
E:\FR\FM\04MRN1.SGM
04MRN1
Agencies
[Federal Register Volume 75, Number 42 (Thursday, March 4, 2010)]
[Notices]
[Page 9912]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4492]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: March 26, 2010.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: Discussion of Programs and Issues.
Place: National Institutes of Health, 6701 Rockledge Drive, 10th
Floor, Conference Room 10091, Bethesda, MD 20892.
Contact Person: W. Keith Hoots, Director, Division of Blood
Diseases and Resources, National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Suite 9030, Bethesda, MD 20892, 301-435-0080,
hootswk@nhlbi.nih.gov.
Information is also available on the Institute's/Center's home
page: http:/www.nhlbi.nih.gov/meetings/index.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: February 23, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-4492 Filed 3-3-10; 8:45 am]
BILLING CODE 4140-01-P